Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Flavio Mantelli
Person

Flavio Mantelli

Tracked across 4 events · 44 articles · First seen May 19, 2026 · Last active Jul 23, 2026

Sentiment
2
Attention
2
Events
4
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (4)
2 0
Regulatory
OKYO Pharma FDA Type D meeting positive
Impact: Flavio Mantelli, Chief Medical Officer, highlighted the FDA feedback as an important milestone and de-risking of the development program.
Jul 08, 2026 · 9 articles
1 10
Business
OKYO Pharma insider share purchases
Impact: Chief Medical Officer purchased 20,000 shares at $1.40.
Jul 21, 2026 · 22 articles
2 0
Business
OKYO_Pharma appoints Marta_Sacchetti to SAB
Impact: Flavio Mantelli>>>, Chief Medical Officer of OKYO Pharma>>>, commented on the strengthening of the Scientific Advisory Board with Marta Sacchetti>>>'s appointment.
May 19, 2026 · 7 articles
0 0
Business
OKYO Pharma at Piper Sandler Symposium
Impact: Chief Medical Officer of OKYO Pharma, presenting at the symposium.
Jul 07, 2026 · 6 articles
Relationships (2)
OKYO Pharma chief medical officer ↔ Flavio Mantelli Flavio Mantelli is the Chief Medical Officer of OKYO Pharma, overseeing the comp
OKYO Pharma ↔ Flavio Mantelli
ERGEN INTELLIGENCE
Track Flavio Mantelli live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.